Certain substituted diphenyl ureas, as modulators of kinase...

Details Certain substituted diphenyl ureas, as modulators of kinase... Certain substituted diphenyl ureas, as modulators of kinase...

2006-01-13

2009-12-01

Davis, Zinna N (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S272700, C546S274100

Reexamination Certificate

active

07625931

ABSTRACT:
Certain chemical entities chosen from compounds of Formula 1 and pharmaceutically acceptable salts, solvates, crystal forms, chelates, non-covalent complexes, prodrugs, and mixtures thereof, are provided herein. Pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle chosen from carriers, adjuvants, and excipients, are also provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to angiogenic kinase modulation, which comprise administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include cancer, including breast neoplasia, endometrial cancer, colon cancer, and neck squamous cell carcinoma. Methods of treatment include administering at least one chemical entity as a single active agent or administering such at least one chemical entity in combination with one or more other therapeutic agents. A method for determining the presence or absence of an angiogenic kinase in a sample comprising contacting the sample with at least one chemical entity under conditions that permit detection of activity of the angiogenic kinase, detecting a level of the activity of the angiogenic kinase, and therefrom determining the presence or absence of the angiogenic kinase in the sample.

REFERENCES:
patent: 4301169 (1981-11-01), Yamanaka et al.
patent: 6344465 (2002-02-01), Armistead et al.
patent: 6541496 (2003-04-01), Armistead et al.
patent: 6627647 (2003-09-01), Betageri
patent: 6645990 (2003-11-01), Askew et al.
patent: 6919340 (2005-07-01), Currie
patent: 7160885 (2007-01-01), Currie et al.
patent: 7189723 (2007-03-01), Mitchell et al.
patent: 7259164 (2007-08-01), Mitchell et al.
patent: 7312341 (2007-12-01), DeSimone et al.
patent: 2003/0212073 (2003-11-01), Currie et al.
patent: 2004/0067951 (2004-04-01), DeSimone et al.
patent: 2004/0220189 (2004-11-01), Sun et al.
patent: 2004/0235892 (2004-11-01), Dai et al.
patent: 2005/0009832 (2005-01-01), Sun et al.
patent: 2005/0054648 (2005-03-01), Mitchell et al.
patent: 2005/0054649 (2005-03-01), Currie et al.
patent: 2005/0085484 (2005-04-01), Mitchell et al.
patent: 2005/0101604 (2005-05-01), Currie et al.
patent: 2005/0288295 (2005-12-01), Currie et al.
patent: 1 170 288 (2002-01-01), None
patent: WO 89/09212 (1989-10-01), None
patent: WO 96/40673 (1996-12-01), None
patent: WO 98/50346 (1998-11-01), None
patent: WO 99/32106 (1999-07-01), None
patent: WO 99/32436 (1999-07-01), None
patent: WO 00/24707 (2000-05-01), None
patent: WO 02/076985 (2002-10-01), None
patent: WO 03/024447 (2003-03-01), None
patent: WO 03/037887 (2003-05-01), None
patent: WO 03/072541 (2003-09-01), None
patent: WO 03/089434 (2003-10-01), None
patent: WO 03/099771 (2003-12-01), None
patent: WO 2004/013141 (2004-02-01), None
patent: WO 2004/022562 (2004-03-01), None
patent: WO 2004/056830 (2004-07-01), None
patent: WO 2004/072080 (2004-08-01), None
patent: WO 2004/072081 (2004-08-01), None
patent: WO 2004/080979 (2004-09-01), None
patent: WO 2004/085425 (2004-10-01), None
patent: WO 2004/100947 (2004-11-01), None
patent: WO 2005/005429 (2005-01-01), None
patent: WO 2005/014599 (2005-02-01), None
patent: WO 2005/019220 (2005-03-01), None
patent: WO 2005/047290 (2005-05-01), None
patent: WO 2005/097755 (2005-10-01), None
Kulkarni et al, Journal of Pharmaceutical Sciences (1969), 58(7), pp. 852-857.
De Lucca et al., 2002, “Discovery and Structure- Activity Relationship of N-(Ureidoalkyl)-Benzyl-Piperidines As Potent Small Molecule CC Chemokine Receptor-3 (CCR3) Antagonists,” J. Med. Chem., 45: 3794-3804.
PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; PCT International Search Report; and the PCT Written Opinion of the International Searching Authority, for PCT/US2006/001271, international filing date Jan. 13, 2006, date of mailing May 26, 2006, 12 pages.
Jeffrey et al. (1998) “Phosphodiesterase III and V Inhibitors on Pulmonary Artery from Pulmonary Hypertensive Rats: Differences Between Early and Established Pulmonary Hypertension,” J. Cardiovascular Pharmacology, 32:213-219.
“Protein Kinases in Disease,” references produced from a Sep. 24, 1997, search of the On-line Meddelian Inheritance in Man (OMIM) database, pp. 1-11, from http://bioinformatics.weizmann.ac.il/Kinases/pkr/pk—medicine.html.
Stenberg et al. (2000) “KinMutBase, a database of human disease-causing protein kinase mutations,” Nucleic Acids Research, 28(1):369-371.
International Search Report dated Feb. 9, 2004, for Application No. PCT/US03/28329, International filing date Sep. 9, 2003.
Written Opinion dated Jul. 6, 2004, for Application No. PCT/US03/28329, International filing date Sep. 9, 2003.
International Preliminary Examination Report dated Oct. 27, 2004, for Application No. PCT/US03/28329, International filing date Sep. 9, 2003.
International Search Report and Written Opinion dated Jul. 7, 2004, for Application No. PCT/US2004/003922, International filing date Feb. 10, 2004.
International Search Report and Written Opinion dated Jul. 7, 2004, for Application No. PCT/US2004/003923, International filing date Feb. 10, 2004.
International Search Report and Written Opinion dated Dec. 8, 2004, for Application No. PCT/US2004/021150, International filing date Jun. 30, 2004.
International Search Report and Written Opinion dated Feb. 1, 2005, for Application No. PCT/US2004/025884, International filing date Aug. 11, 2004.
International Search Report and Written Opinion dated Jun. 23, 2005, for Application No. PCT/US2004/037433, International filing date Nov. 10, 2004.
Office Action dated Apr. 3, 2006, for U.S. Appl. No. 10/776,002, filed Feb. 10, 2004.
Office Action dated May 24, 2006, for U.S. Appl. No. 10/776,631, filed Feb. 10, 2004.
Notice of Allowance dated Aug. 11, 2006, for U.S. Appl. No. 10/776,002, filed Feb. 10, 2004.
Notice of Allowance dated Sep. 7, 2006, for U.S. Appl. No. 10/776,631, filed Feb. 10, 2004.
Office Action dated Sep. 26, 2006, for U.S. Appl. No. 10/658,121, filed Sep. 9, 2003.
Notice of Allowance dated Mar. 6, 2007 for U.S. Appl. No. 10/658,121, filed Sep. 9, 2003.
Notice of Allowance dated Aug. 8, 2007 for U.S. Appl. No. 10/658,121, filed Sep. 9, 2003.

Affiliated with

Also associated with

Rating

Certain substituted diphenyl ureas, as modulators of kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Certain substituted diphenyl ureas, as modulators of kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain substituted diphenyl ureas, as modulators of kinase... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4148652